Sponsors and Exhibitors

Before a molecule becomes a drug it needs to be accepted as a clinical candidate. Before that, numerous compounds are tested thoroughly ensuring right selection. ADME-Tox research is a crucial part of this path. The right assays are available, from discovery and lead optimization to development. The broad portfolio offers in vitro and in vivo assays from small molecules to biologics. As part of Symeres, we aim to have positive impact on people's lives. We make molecules matter. Together. Admescope

With our high production capabilities and robust QC & QA processes, BioIVT is your trusted partner for hepatocytes, NPCs & subcellular fractions.  Our contract research services capabilities and expert consulting team enable you to accelerate your ADME programs and develop comprehensive ADME strategies designed to accomplish your R&D goals. BioIVT

Pharmaron is a global R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 19,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners around the globe. Pharmaron

SOLVO, originally a pioneer in transporter research, now provides a full range of in vitro ADME assays for hundreds of clients globally. Access our in-depth portfolio ranging from screening- and custom assays all the way regulatory studies. As a Charles River company, we also provide access to end-to-end DMPK solutions. SOLVO Biotechnology

SCIEX helps scientists in pharma discovery, development, and manufacturing to transform pipeline capacity and capability through the adoptions of CE and LC-MS technologies. You benefit from innovative technology that makes complex workflows easier and more efficient, while delivering the utmost in data quality. Highly relative instrumentation, with high sensitivity and dynamic range for a variety of analytical applications. Advanced software with automation to make data processing easier. SCIEX

Unilabs is an international provider of healthcare services, with over 14,000 employees in 20 countries. A key component of the Unilabs portfolio is to provide support to the pharmaceutical industry via medical imaging, histopathology, flow cytometry, molecular diagnostics, bioanalysis and ADME study support. Of particular interest to DMPK groups are the centres of excellence in bioanalysis, in vitro ADME and metabolism. Bioanalytical support comprises GLP-accredited laboratories based in York, UK and Copenhagen, Denmark, as well as non-GLP facilities based in Sandwich, UK. Metabolism and in vitro ADME expertise are provided by the team in Sandwich, supporting all aspects of metabolite characterisation, including in vitro experiments, clinical studies and definitive radiolabelled studies and providing a full range of in vitro ADME activities, such as metabolic clearance measurements, stability studies, binding and related distribution studies, permeability assessments, drug transporter substrate/inhibition studies and determinations of enzyme inhibition and induction. York Bioanalytical Solutions

Elsevier, a global information and analytics business, helps researchers advance R&D with trusted scientific data via end-user solutions, APIs and Services.

SciBite, from Elsevier, is a data-first scientific software company that enables FAIR standards by providing ontologies, text analytics and semantic search to help researchers find, share, and organize information. Elsevier

AIM Research Company is the industry leader in online radioactivity detection and fraction collection technologies. Our vARC3 and LCJet systems are utilized by major corporations and CROs around the world to deliver peerless performance and consistent results.
AIM Research Company

Concept Life Sciences is a knowledge-based, science-led and customer-focused contract research and manufacturing organisation with world-leading expertise in the pharmaceutical, biotech and agrochemical industries. We offer a wide range of in vitro ADMET screens, in vivo DMPK bioanalysis techniques and metabolite analyses services to support the early assessment of compounds, through to regulatory bioanalysis appropriate for submission to authorities. Concept Life Sciences

Cyprotex was founded in 1999 and specialises in in vitro and in silico ADME-Tox. The company has sites in the UK and US. In 2016, Cyprotex was acquired by Evotec AG (www.evotec.com). As a whole, the Group offer expert support from early discovery through to preclinical development and beyond. Cyprotex US LLC

GenoMembrane Co., Ltd specializes in the research and development of drug transporters. We provide transporter-related products and research services. In order to contribute to pharmacokinetic study, we offer ABC transporter vesicle products and cryopreserved HEK293 cells transiently expressed SLC transporter to help our clients to facilitate the drug discovery. GenoMembrane

Experts in metabolite synthesis and
characterization.
Hypha Discovery

Instem is a leading supplier of innovative software and services for the pharmaceutical and biopharmaceutical industry for Discovery, Development and Clinical Trials. Our solutions are used by project teams and scientists from disciplines such as DMPK, Pharmacology, ADME, Toxicology, in vivo & in vitro Biology. We provide solutions for requesting services, managing demand, supplying compound inventory as well as executing assays using our software platform BioRails. Our solutions facilitate today's insourced/outsourced research and development environment which demands modern approaches for the desktop, intranet and cloud. Instem

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. Learn more about Labcorp at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. Labcorp Drug Development

LabLogic is a premier instrument and software provider supporting PET/nuclear medicine facilities, pharmaceutical companies, agrochemical research, universities and contract research organisations for over 35 years. Our systems for radio-HPLC, radio-TLC and other laboratory instruments are designed to provide unrivalled sensitivity and limits of detection to satisfy the most demanding requirements. LabLogic

Pharmidex is an award winning GLP-accredited CRO with extensive expertise in drug discovery. Since 2002, Pharmidex has delivered high levels of customer satisfaction focusing on drug discovery (CNS, Oncology, Respiratory, Dermatology and Stroke), in vitro ADMET, DMPK, PKPD, bioanalysis, metabolite identification, and GLP-toxicology. Pharmidex has extensive experience in grant funded collaborations. Pharmidex

Production and Distribution of Biological Assay Systems. PRIMACYT GmbH

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast. Quotient Sciences

TNO is supporting sponsors active in drug development with innovative platforms and services. Via in vitro and ex vivo platforms we predict PK and metabolism. Our u-dosing/tracer AMS capabilities accelerate and de-risk clinical development by generating early human PK, metabolism and mass balance data. TNO is also involved in microbiome analysis incl. microbiome mediated drug metabolism. TNO (Efficient Drug Development)